T

ThromboGenics NV

53 employees

Oxurion is a biotech drug development company focused on developing therapies for retinal disorders, now focusing on diabetic eye diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Medical
Life Science

Date founded

1991

Funding rounds raised

Total raised

$12M

from 2 investors over 2 rounds

T

ThromboGenics NV raised $3M on March 2, 2023

Investors: -

T

ThromboGenics NV raised $12M on March 3, 2022

Investors: Epacria Capital Partners

FAQ